Patents by Inventor Muruganandam Veeraragavan

Muruganandam Veeraragavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-DIABETIC ACTIVITY OF NEEM EXTRACT AND SYNERGISTIC COMBINATIONS OF UROLITHINS A AND B
    Publication number: 20200138892
    Abstract: Methods of treating symptoms of type 2 diabetes in a human subject by administering a composition comprising urolithin A and urolithin B, are provided. Methods of treating symptoms of type 2 diabetes and metabolic syndrome in a human subject by administering a composition comprising neem extract are provided.
    Type: Application
    Filed: November 4, 2019
    Publication date: May 7, 2020
    Applicant: Natreon, Inc.
    Inventors: Muruganandam A. Veeraragavan, Chandan K. Sen, Sanyasi R. Kalidindi
  • Indolealkylamino-withasteroid conjugates and method of use
    Patent number: 10449206
    Abstract: A group of indolealkylamino-withasteroid conjugates, isolated and purified from Withania somnifera, are described. A synthetic method of making an indolealkylamino-withasteroid compound is provided. In vitro acetyl cholinesterase inhibitory activity and methods for treatment of dementia and dementia-related disorders, such as Alzheimer's disease, and anxiety and depressive disorders in mammals are demonstrated with these novel compositions.
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: October 22, 2019
    Assignee: Natreon, Inc.
    Inventors: Shibnath Ghosal, Muruganandam Veeraragavan, Sanyasi R. Kalidindi
  • INDOLEALKYLAMINO-WITHASTEROID CONJUGATES AND METHOD OF USE
    Publication number: 20150320771
    Abstract: A group of indolealkylamino-withasteroid conjugates, isolated and purified from Withania somnifera, are described. A synthetic method of making an indolealkylamino-withasteroid compound is provided. In vitro acetyl cholinesterase inhibitory activity and methods for treatment of dementia and dementia-related disorders, such as Alzheimer's disease, and anxiety and depressive disorders in mammals are demonstrated with these novel compositions.
    Type: Application
    Filed: July 21, 2015
    Publication date: November 12, 2015
    Applicant: NATREON, INC.
    Inventors: Shibnath Ghosal, Muruganandam Veeraragavan, Sanyasi R. Kalidindi
  • Indolealkylamino-withasteroid conjugates and method of use
    Patent number: 9084800
    Abstract: A group of indolealkylamino-withasteroid conjugates, isolated and purified from Withania somnifera, are described. A synthetic method of making an indolealkylamino-withasteroid compound is provided. In vitro acetyl cholinesterase inhibitory activity and methods for treatment of dementia and dementia-related disorders, such as Alzheimer's disease, and anxiety and depressive disorders in mammals are demonstrated with these novel compositions.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: July 21, 2015
    Assignee: Natreon, Inc.
    Inventors: Shibnath Ghosal, Muruganandam Veeraragavan, Sanyasi R. Kalidindi
  • Compositions and method for improving endothelial function and cardiovascular health
    Patent number: 8962576
    Abstract: Compositions of natural antioxidants, especially those derived from Phyllanthus emblica and Withania somnifera, and combinations thereof, are provided. The compositions may be used for improvement of endothelial function and cardiovascular health, including treatment of diabetes.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: February 24, 2015
    Assignee: Natreon, Inc.
    Inventors: Shibnath Ghosal, Muruganandam Veeraragavan, Sanyasi R. Kalidindi
  • TERMINALIA CHEBULA COMPOSITIONS AND METHOD OF EXTRACTING SAME
    Publication number: 20130266676
    Abstract: An enriched hydrolyzable tannoid blend derived from Terminalia chebula is provided. An optimized aqueous extraction method for Terminalia chebula is provided to maximize the levels of bioactive hydrolyzable tannoids including chebulagic acid, chebulinic acid and other low molecular weight hydrolyzable tannoids. The method produces a Terminalia chebula extract containing a hydrolyzable tannoid blend as an amorphous dry powder. In an embodiment, the Terminalia chebula extract contains 8-25% by weight chebulagic acid, 15-30% chebulinic acid, and 5-45% low molecular weight hydrolyzable tannoids. Potential uses of said enriched hydrolyzable tannoid compositions for antioxidant activity in a human subject are described herein.
    Type: Application
    Filed: April 9, 2013
    Publication date: October 10, 2013
    Applicant: Natreon, Inc.
    Inventors: Shibnath Ghosal, Muruganandam Veeraragavan, Sanyasi R. Kalidindi
  • COMPOSITIONS AND METHOD FOR IMPROVING ENDOTHELIAL FUNCTION AND CARDIOVASCULAR HEALTH
    Publication number: 20130261068
    Abstract: Compositions of natural antioxidants, especially those derived from Phyllanthus emblica and Withania somnifera, and combinations thereof, are provided. The compositions may be used for improvement of endothelial function and cardiovascular health, including treatment of diabetes.
    Type: Application
    Filed: March 26, 2013
    Publication date: October 3, 2013
    Applicant: Natreon, Inc.
    Inventors: Shibnath Ghosal, Muruganandam Veeraragavan, Sanyasi R. Kalidindi